Knight Therapeutics Inc. announced that Jonathan Ross Goodman has resigned from the company's Board of Directors, effective . Mr. Goodman has been a Director since June 2013. Samira Sakhia will replace Mr. Goodman as chair of the Audit Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6 CAD | 0.00% | -1.15% | +15.61% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 445M | |
+16.17% | 79.16B | |
+8.08% | 8.72B | |
-16.43% | 4.79B | |
+48.34% | 4.62B | |
+2.91% | 3.82B | |
+14.51% | 2.33B | |
-26.94% | 2.2B | |
+16.55% | 2.1B | |
-36.25% | 2.04B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Inc. Announces Board Changes